In preclinical investigations, quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC) can be employed to compare the relative levels of AR-regulated markers and the NEPC marker DLL3 in PCa cell lines [101]. This evidence concerns the gene AR and posterior cortical atrophy.